Alterity Financial Statements From 2010 to 2025

Alterity Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 21.7 M 22.1 M 24 M Pretty Stable Cash 15.7 M 14.5 M 18.7 M Very volatile Cash And Short Term Investments 15.7 M 14.5 M 18.7 M Very volatile Common Stock Shares Outstanding 7.3 M 7 M 2.4 M Slightly volatile Liabilities And Stockholders Equity 21.7 M 22.1 M 24 M Pretty Stable Total Liabilities 6.6 M 6.2 M 3.5 M Slightly volatile Total Current Assets 18.7 M 21.9 M 23.7 M Pretty Stable Common Stock 269.5 M 256.6 M 162.6 M Slightly volatile Other Current Liabilities 5.6 M 5.4 M 2.5 M Slightly volatile Total Current Liabilities 6.5 M 6.2 M 3.5 M Slightly volatile Property Plant And Equipment Net 225.7 K 214.9 K 110.9 K Slightly volatile Accounts Payable 1.1 M 668.3 K 925.1 K Slightly volatile Non Current Assets Total 159.8 K 168.2 K 974 K Slightly volatile Net Receivables 2.8 M 4.6 M 4 M Pretty Stable Other Current Assets 2.8 M 2.7 M 1 M Slightly volatile Common Stock Total Equity 128.1 M 227.1 M 150.2 M Slightly volatile Non Current Liabilities Total 68.3 K 46.7 K 31.5 K Slightly volatile Property Plant And Equipment Gross 747.5 K 711.9 K 263.3 K Slightly volatile Other Liabilities 15 K 22.4 K 11.5 K Slightly volatile Net Tangible Assets 24.6 M 26.2 M 21.7 M Slightly volatile Property Plant Equipment 324.7 K 309.2 K 122.3 K Slightly volatile Net Invested Capital 22.8 M 15.9 M 21.7 M Pretty Stable Net Working Capital 22.7 M 15.7 M 21.6 M Pretty Stable Capital Stock 213.7 M 256.6 M 180.6 M Slightly volatile
Alterity Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Other Operating Expenses 28.5 M 27.2 M 13.9 M Slightly volatile Total Revenue 4.9 M 4.6 M 1.8 M Slightly volatile Research Development 22.5 M 21.4 M 11.7 M Slightly volatile Depreciation And Amortization 227.3 K 132.8 K 136.6 K Pretty Stable Selling General Administrative 3.6 M 4.3 M 4.3 M Pretty Stable Selling And Marketing Expenses 8.3 K 8.7 K 108.8 K Slightly volatile Interest Income 229.5 K 241.6 K 1.6 M Slightly volatile Net Interest Income 253.7 K 241.6 K 128.6 K Pretty Stable Reconciled Depreciation 178.1 K 169.7 K 65 K Slightly volatile
Alterity Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Begin Period Cash Flow 17.6 M 18.1 M 19.2 M Pretty Stable Depreciation 197.5 K 132.8 K 136 K Pretty Stable Capital Expenditures 4.9 K 5.1 K 26.5 K Slightly volatile End Period Cash Flow 17.9 M 14.5 M 19 M Very volatile Issuance Of Capital Stock 11.2 M 9.1 M 13.1 M Very volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 3.88 4.09 161 Slightly volatile Days Sales Outstanding 314 330 4.9 K Slightly volatile Average Payables 2.1 M 2 M 1.2 M Slightly volatile Capex To Depreciation 0.0332 0.0349 0.6842 Slightly volatile Sales General And Administrative To Revenue 1.02 1.07 11.4114 Slightly volatile Research And Ddevelopement To Revenue 3.97 4.17 29.9409 Slightly volatile Capex To Revenue 0.0016 0.0016 0.0782 Slightly volatile Cash Per Share 0.0038 0.004 0.0259 Slightly volatile Income Quality 0.75 0.59 1.0003 Slightly volatile Intangibles To Total Assets 0.3 0.32 0.3128 Slightly volatile Net Debt To EBITDA 0.7 0.73 1.5488 Slightly volatile Current Ratio 6.21 3.19 7.8044 Pretty Stable Receivables Turnover 1.09 1.14 0.9147 Pretty Stable Debt To Equity 0.025 0.0133 0.0149 Slightly volatile Capex Per Share 0.0 0.0 1.0E-4 Slightly volatile Average Receivables 6 M 5.7 M 4.7 M Slightly volatile Revenue Per Share 0.0012 0.0013 0.0011 Slightly volatile Interest Debt Per Share 0.0 1.0E-4 3.0E-4 Slightly volatile Debt To Assets 0.009 0.0095 0.011 Slightly volatile Operating Cycle 314 330 6.2 K Slightly volatile Ebt Per Ebit 1.14 1.12 0.9812 Pretty Stable Total Debt To Capitalization 0.0239 0.0131 0.0144 Slightly volatile Debt Equity Ratio 0.025 0.0133 0.0149 Slightly volatile Quick Ratio 6.17 3.19 7.7547 Pretty Stable Net Income Per E B T 0.79 0.9 0.9644 Slightly volatile Cash Ratio 2.57 2.7 6.1726 Slightly volatile Days Of Sales Outstanding 314 330 4.9 K Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.11 1.15 1.02 Slightly volatile Fixed Asset Turnover 20.32 19.36 14.3433 Slightly volatile Debt Ratio 0.009 0.0095 0.011 Slightly volatile Price Sales Ratio 3.88 4.09 161 Slightly volatile Asset Turnover 0.2 0.19 0.0751 Slightly volatile
Alterity Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 19.9 M 21 M 38.8 M Slightly volatile

Alterity Fundamental Market Drivers

About Alterity Therapeutics Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Alterity Therapeutics is a strong investment it is important to analyze Alterity Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alterity Therapeutics' future performance. For an informed investment choice regarding Alterity Stock, refer to the following important reports:

How To Invest In Alterity Details

Is Alterity Stock a good investment? Details

What is Alterity Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details